ANGO
Research Snapshot
Static fundamentals, valuation context, and investor signals for AngioDynamics, Inc. (ANGO).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
-18.6%
ROIC, -5.0% FCF margin
Growth
2.1%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 2.2x current ratio
Superinvestors
1
Top: First Eagle Investment Management (0.0%)
Strengths to research
- Debt/equity looks manageable at 0.0x.
- 10 annual periods are available for trend analysis.
Watchouts
- Free cash flow margin is negative at -5.0%.
- Valuation multiples are limited or unavailable.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for ANGO.
Grade F
17
/ 100
Financial Charts
No financial data available for ANGO (annual).
1 superinvestors own ANGO
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 275,735 | $3M | 0.01% | 0.0% |